Archive

Neovasc Announces Closing of $5 Million Public Offering of Common Shares

NASDAQ, TSX: NVCN VANCOUVER, March 15, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN / TSX: NVCN) announced today that it has closed its previously announced underwritten public offering (the "Offering") of 11,111,111 common shares of the Company (the "Common Shares") at...

Read More

Neovasc Completes Successful Quality System Surveillance Audit

NASDAQ, TSX: NVCN VANCOUVER, March 14, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory...

Read More

Neovasc Announces Pricing of $5 Million Public Offering of Common Shares

NASDAQ, TSX: NVCN VANCOUVER, March 13, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN / TSX: NVCN) announced today the pricing of its previously announced underwritten public offering (the "Offering") of 11,111,111 common shares of the Company (the "Common Shares") at a...

Read More

Neovasc Announces Proposed Public Offering of Common Shares

NASDAQ, TSX: NVCN VANCOUVER, March 12, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN / TSX: NVCN) announced today that it has commenced a proposed underwritten public offering (the "Offering") of common shares of the Company (the "Common Shares"). H.C. Wainwright...

Read More

Neovasc Announces Agreements to Exchange Outstanding Warrants for Shares

NASDAQ, TSX: NVCN VANCOUVER, March 12, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVCN) announced today that it has entered into exchange agreements ("Exchange Agreements") with the holders ("Holders") of all of its outstanding Series A common share purchase warrants...

Read More